Filing Details
- Accession Number:
- 0000950170-24-101450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-28 17:00:03
- Reporting Period:
- 2024-08-27
- Accepted Time:
- 2024-08-28 17:00:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 16040 | Cabot Corp | CBT | Miscellaneous Chemical Products (2890) | 042271897 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740348 | Erica Mclaughlin | C/O Cabot Corporation Two Seaport Lane, Suite 1400 Boston MA 02210 | Executive Vice President, Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-27 | 4,676 | $50.00 | 64,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-27 | 4,676 | $104.49 | 59,814 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-08-27 | 11,714 | $50.23 | 71,528 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-27 | 11,714 | $104.14 | 59,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2024-08-27 | 4,676 | $0.00 | 4,676 | $50.00 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2024-08-27 | 11,714 | $0.00 | 11,714 | $50.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-11-08 | No | 4 | M | Direct | |
| 0 | 2029-11-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2 | Indirect | Through the Trustee for the Corporation's 401(k) Plan |
Footnotes
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.120 to $104.510, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- 23,710 shares were subject to the option. The option vested over a three year period as follows: 30% on November 9, 2019, 30% on November 9, 2020 and 40% on November 9, 2021.
- 27,036 shares were subject to the option. The option vested over a three year period as follows: 30% on November 8, 2020, 30% on November 8, 2021 and 40% on November 8, 2022.
Billionaire Hedge Funds
